The aim of the present study was to compare the long term clinical and radiographic success rates of Biodentine and MTA pulpotomies, performed on primary teeth with carious pulpal exposure.
MATERIALS AND METHODS
For the study, 44 mandibular primary vital molars requiring pulpotomy were selected. The inclusion criteria were the presence of carious dentin surrounding the site of pulpal exposure, spontaneous pain absence, no tenderness to percussion or palpation, no history of swelling or sinus tract, no radiographic sign of internal/external root resorption, no widened periodontal space, no furcal or periapical radiolucency and finally the possibility of a stainless steel crown restoration. 24 teeth were treated with MTA, and 20 teeth were treated with Biodentine.
The children were recalled periodically for 2 years post treatment. At each follow-up visit, clinical and radiographic examinations were performed by two calibrated blinded examiners. The clinical success criteria were the absence of spontaneous pain, pathologic mobility, tenderness to percussion, swelling , fistula and gingival inflammation, whereas the absence of internal/ external root resorption and periapical/furcal radiolucency was considered as a radiographic success.
RESULTS
Clinical and radiographic success rates, after two follow up years, were 100% for MTA group and 89,4% for Biodentine group. The difference between the groups in the success rates wasn’t statistically significant (p=0,646).
CONCLUSIONS
As Biodentine and MTA showed no statistically significant difference in the success rates when applied on the canal orifices during pulpotomy procedures, Authors concluded that the shorter setting time and the easier handling make Biodentine to be preferred to MTA. However, clinical trials with longer follow up periods are required before any conclusive recommendation could be made.
CLINICAL RELEVANCE
As already stated and accepted, carious tissue around the site of exposure means pulpal contamination and inflammation, resulting in an uncertain and unpredictable prognosis for the treated teeth. MTA and Biodentine are expected to transform the inflammation process into a healing process due to their tricalcium silicate contents and their biointeractive properties.
For additional informations:
Çelik, B.N., Mutluay, M.S., Arıkan, V. et al. Clin Oral Invest (2019) Volume 23 Issue 2, pages 661-666 Published online 10th May 2018
No clinical studies have examined the effect of mineral trioxide aggregate (MTA) obturation levels on the outcome of endodontic retreatment. This retrospective study examined treatment outcomes in...
The study published in the Journal of Endodontics, conducted by Gorni et al, investigated the prognostic factors and outcome, after 14 years, of elements perforated and treated with MTA.
External cervical resorption is a type of dental resorption that originates from the loss of the cementum's protective layer.
By Arianna Bianchi
Endodontic therapy is one of the most used techniques in dentistry, allowing the removal of contaminated or damaged pulp tissue and replacing it with a biocompatible synthetic material to prevent...
Direct pulp capping is a procedure that has been used for many years, and involves placing a special material directly on the exposed part of the dental pulp with the aim of preserving its vitality...
Editorials 16 April 2024
Dr. Kyle Vining Earns Hartwell Foundation Award to Study Childhood Leukemia
Every year, thousands of American children are diagnosed with acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. The disease begins in bone marrow, when immature cells...
News 16 April 2024
The UF College of Dentistry notched a record turnout for its annual celebration of research – Spring Synergy – on Friday, March 29 at the HPNP Auditorium
Products 16 April 2024
Glidewell recently announced a rebrand of its flagship Hahn Tapered Implant System, now known as the Glidewell HT Implant System.
Market 16 April 2024
Zentist Launches Cavi AR, an RCM Software for Dental Insurance AR & Claims Management
Zentist, the leading cloud-based insurance Revenue Cycle Management (RCM) software for U.S. dental groups, proudly announces the introduction of Cavi AR, an additional innovative solution that is...
News 16 April 2024
Standard Dental Labs Sets Sights on Expansion Following Strong FYE 2023 Performance
Costas, Inc., operating as Standard Dental Labs Inc., a renowned name in the dental industry, is pleased to announce the filing of its annual report for the fiscal year ending 2023 on April 10th,...